Insulin use and smoking jointly increase the risk of bladder cancer mortality in patients with type 2 diabetes

Clinical Genitourinary Cancer

Volumn 11, Issue 4, 2013, Pages 508-514

  Tseng, Chin Hsiao ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Bladder cancer; Insulin; Mortality; Taiwan; Type 2 diabetes mellitus

Indexed keywords

INSULIN;

ADULT; AGE; AGED; ARTICLE; BLADDER CANCER; CANCER MORTALITY; CANCER RISK; DISEASE DURATION; FEMALE; GENDER; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SMOKING;

BLADDER CANCER; INSULIN; MORTALITY; TAIWAN; TYPE 2 DIABETES MELLITUS;

AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK; RISK FACTORS; SEX FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 84887988001     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2013.04.019     Document Type: Article

References (32)

1. S.C. Larsson, N. Orsini, and K. Brismar Diabetes mellitus and risk of bladder cancer: a meta-analysis Diabetologia 49 2006 2819 2823
2. T. Mackenzie, M.S. Zens, and A. Ferrara Diabetes and risk of bladder cancer: evidence from a case-control study in New England Cancer 117 2011 1552 1556
3. A. Tripathi, A.R. Folsom, and K.E. Anderson Iowa Women's Health Study. Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study Cancer 95 2002 2316 2323
4. S.C. Larsson, S.O. Andersson, and J.E. Johansson Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men Eur J Cancer 44 2008 2655 2660
5. C.H. Tseng, C.K. Chong, and C.P. Tseng Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year follow-up of a national cohort in Taiwan Ann Med 41 2009 371 379
6. C.H. Tseng Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan Diabetologia 54 2011 2009 2015
7. E. Giovannucci, D.M. Harlan, and M.C. Archer Diabetes and cancer: a consensus report Diabetes Care 33 2010 1674 1685
8. L.G. Hemkens, U. Grouven, and R. Bender Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study Diabetologia 52 2009 1732 1744
9. R. Ruiter, L.E. Visser, and M.P. van Herk-Sukel Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study Diabetologia 55 2012 51 62
10. P. Blin, R. Lassalle, and C. Dureau-Pournin Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database Diabetologia 55 2012 644 653
11. C.H. Tseng Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: a 12-year follow-up study BJU Int 110 2012 668 673
12. C.H. Tseng Diabetes, insulin use, and non-Hodgkin lymphoma mortality in Taiwan Metabolism 61 2012 1003 1009
13. C.H. Tseng Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor? CMAJ 174 2006 319 323
14. C.H. Tseng Effect of parental hypertension and/or parental diabetes on hypertension in Taiwanese diabetic patients Eur J Clin Invest 37 2007 870 877
15. P. Kurtzhals, L. Schäffer, and A. Sørensen Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use Diabetes 49 2000 999 1005
16. S.D. Hursting, S.N. Perkins, and J.A. Lavigne Urothelial overexpression of insulin-like growth factor-1 increases susceptibility to p-cresidine-induced bladder carcinogenesis in transgenic mice Mol Carcinog 48 2009 671 677
17. D. Metalli, F. Lovat, and F. Tripodi The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin Am J Pathol 176 2010 2997 3006
18. H. Zhao, H.B. Grossman, and M.R. Spitz Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk J Urol 169 2003 714 717
19. J.A. Watson, K. Burling, and P. Fitzpatrick Urinary insulin-like growth factor 2 identifies the presence of urothelial carcinoma of the bladder BJU Int 103 2009 694 697
20. D. Ornskov, E. Nexo, and B.S. Sorensen Insulin-induced proliferation of bladder cancer cells is mediated through activation of the epidermal growth factor system FEBS J 273 2006 5479 5589
21. S. Liu, Y. Li, and T. Lin High dose human insulin and insulin glargine promote T24 bladder cancer cell proliferation via PI3K-independent activation of Akt Diabetes Res Clin Pract 91 2011 177 182
22. C.H. Tseng Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan BMC Cancer 13 2013 7
23. B.G. Timms, and L.E. Hofkamp Prostate development and growth in benign prostatic hyperplasia Differentiation 82 2011 173 183
24. K. Sorimachi, Y. Yasumura, and T. Kakuya Upregulation of insulin receptors with dexamethasone in cultured human urinary bladder carcinoma cells Endocrinol Jpn 30 1983 723 729
25. M.A. Rochester, N. Patel, and B.W. Turney The type 1 insulin-like growth factor receptor is over-expressed in bladder cancer BJU Int 100 2007 1396 1401
26. M.R. Safarinejad, N. Shafiei, and S.H. Safarinejad The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene Arch Toxicol 85 2011 1209 1218
27. E.C. Hwang, Y.J. Kim, and I.S. Hwang Impact of diabetes mellitus on recurrence and progression in patients with non-muscle invasive bladder carcinoma: a retrospective cohort study Int J Urol 18 2011 769 776
28. J.D. Lewis, A. Ferrara, and T. Peng Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study Diabetes Care 34 2011 916 922
29. C.H. Tseng, and F.H. Tseng Peroxisome proliferator-activated receptor agonists and bladder cancer: lessons from animal studies J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 30 2012 368 402
30. C.H. Tseng Pioglitazone and bladder cancer: a population-based study of Taiwanese Diabetes Care 35 2012 278 280
31. C.V. Rizos, and M.S. Elisaf Metformin and cancer Eur J Pharmacol 705 2013 96 108
32. S. Selinski, M.L. Lehmann, and M. Blaszkewicz Urinary bladder cancer risk in relation to a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor-binding protein-3 (IGFBP3) gene Arch Toxicol 86 2012 195 203